Knudsen, Andreas D.
Bouazzi, Randa
Afzal, Shoaib
Gelpi, Marco
Benfield, Thomas
Høgh, Julie
Thomsen, Magda Teresa
Trøseid, Marius
Nordestgaard, Børge G.
Nielsen, Susanne D.
Funding for this research was provided by:
Novo Nordisk Fonden
Augustinus Fonden
Lundbeckfonden
Rigshospitalet Research Council
Article History
Received: 9 September 2021
Accepted: 4 May 2022
First Online: 11 May 2022
Declarations
:
: All participants provided written informed consent. Both the COCOMO study (H-8-2014-0004) and the CGPS study (H-KF-01-144/01) have obtained approval from the Ethics Committee of the Capital Region and from the Danish Data Protection Agency. All methods were performed in accordance with relevant guidelines and regulations and in accordance with the Declaration of Helsinki.
: Not applicable.
: A.D.K has received a grant from The Danish Heart Foundation and a travelling grant from Gilead unrelated to this manuscript; S.D.N. has received unrestricted research grants from Novo Nordisk Foundation, Lundbeck Foundation, Augustinus Foundation, Rigshospitalet Research Council. Travelling grants from Gilead. Advisory board activity for Gilead and GSK/ViiV, all unrelated to this manuscript. All other authors report no conflicts of interest.